PNC Financial Services Group
BBNX

PNC Financial Services Group’s Beta Bionics BBNX Stock Holding History

PNC Financial Services Group’s Portfolio BBNX Stock Details BBNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$815 Sell
52
-12
-19% -$143 ﹤0.01% 4881
2026
Q1 		$641 Sell
64
-36
-36% -$532 ﹤0.01% 4856
2025
Q4 		$3.05K Buy
100
+50
+100% +$1.33K ﹤0.01% 4417
2025
Q3 		$994 Hold
50
– – ﹤0.01% 4676
2025
Q2 		$728 Hold
50
– – ﹤0.01% 4619
2025
Q1 		$612 Buy
+50
New +$932 ﹤0.01% 4604

Other funds holding BBNX

EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $614M AUM 19.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

PNC Financial Services Group's BBNX Position: Q2 2026 in Review

PNC Financial Services Group reduced its Beta Bionics (BBNX) stake by 19% in Q2 2026, selling an estimated $143 and leaving 52 shares worth $815. The position accounts for ﹤0.01% of the portfolio, ranked #4881.

PNC Financial Services Group first reported a position in BBNX in Q1 2025 and has held it in 6 quarters since. The position peaked at $3.05K in Q4 2025. 133 funds tracked by Wall St. Rank hold BBNX as of Q2 2026.

  • PNC Financial Services Group held 52 shares of Beta Bionics worth $815 as of Q2 2026.
  • PNC Financial Services Group sold 12 Beta Bionics shares in Q2 2026, an estimated $143.
  • Beta Bionics made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #4881 holding.
  • PNC Financial Services Group first reported a position in Beta Bionics in Q1 2025 and has held it in 6 quarters since.
  • PNC Financial Services Group's Beta Bionics position peaked at $3.05K in Q4 2025.
  • 133 funds tracked by Wall St. Rank held Beta Bionics as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.